N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission

N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission Michael Weber, Oscar Bazzino, Jose L. Navarro Estrada, Juan J. Fuselli, Fernando Botto, Diego Perez de Arenaza, Helge Möl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2008-03, Vol.51 (12), p.1188-1195
Hauptverfasser: Weber, Michael, MD, Bazzino, Oscar, MD, Navarro Estrada, Jose L., MD, Fuselli, Juan J., MD, Botto, Fernando, MD, Perez de Arenaza, Diego, MD, Möllmann, Helge, MD, Nef, Holger N., MD, Elsässer, Albrecht, MD, Hamm, Christian W., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1195
container_issue 12
container_start_page 1188
container_title Journal of the American College of Cardiology
container_volume 51
creator Weber, Michael, MD
Bazzino, Oscar, MD
Navarro Estrada, Jose L., MD
Fuselli, Juan J., MD
Botto, Fernando, MD
Perez de Arenaza, Diego, MD
Möllmann, Helge, MD
Nef, Holger N., MD
Elsässer, Albrecht, MD
Hamm, Christian W., MD
description N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission Michael Weber, Oscar Bazzino, Jose L. Navarro Estrada, Juan J. Fuselli, Fernando Botto, Diego Perez de Arenaza, Helge Möllmann, Holger N. Nef, Albrecht Elsässer, Christian W. Hamm We aimed to determine the prognostic value of N-terminal B-type natriuretic peptide (NT-proBNP) in 2,614 troponin negative (troponin T ≤0.01 ng/ml) patients from 2 different registries with evident or suspected acute coronary syndromes (ACS). In these two cohorts, receiver-operating characteristic curve analysis yielded an optimal cutoff value of 474 pg/ml for NT-proBNP that was able to discriminate patients at higher risk in the Bad Nauheim ACS and Prognosis in Acute Coronary Syndromes registries (mortality rate 12.3% vs. 1.3%, p < 0.001 and 8.5% vs. 1.5%, p < 0.001, respectively). Therefore, our study, in combination with previously published data, strongly suggests the implementation of NT-proBNP assessment for risk stratification of patients with chest pain or suspected non–ST-segment elevation ACS and negative troponin values.
doi_str_mv 10.1016/j.jacc.2007.11.054
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68095717</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109708000788</els_id><sourcerecordid>68095717</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-a65016244035941a8c5d79a4e0c4ab58132ce9d3e5ac9fb8781d6af3b7e2dab93</originalsourceid><addsrcrecordid>eNp9kt2O0zAQhSMEYsvCC3CBLCG4S7GTOHYktFKp-Km0KpW2C5eWa0_AJbGLnazU1-IJmagVK-0FV3HG35lMzpkse8nonFFWv9vP99qYeUGpmDM2p7x6lM0Y5zIveSMeZzMqSp4z2oiL7FlKe0ppLVnzNLtgsuS85mKW_VnnW4i987ojH_Lt8QBkrYfoxgiDM2QDh8FZIIuUIKUe_EA2MdxhKZGVNxGmEkqx-MOHNElWvg2x14MLnjhPNnhCJpHvbvhJFmYcgCxDDF7HI7k5ehtDj820t2Q96TqyjeEQPEq35JvuRry8xXeysL1LCbs-z560ukvw4vy8zG4_fdwuv-TXXz-vlovr3HBaDrmuOZpUVBVFNyqmpeFWNLoCaiq945KVhYHGlsC1adqdFJLZWrflTkBh9a4pL7O3p76HGH7jGIPCAQx0nfYQxqRqSRsumEDw9QNwH8aIjibFOK0LKkRRIlWcKBNDShFadYiuRxcUo2rKU-3VlKea8lSMKcwTRa_OrcddD_Zecg4QgTdnQCejuzZqb1z6xxW0QJRy5N6fOEDH7hxElQzmYsC6CGZQNrj_z3H1QG465x1-8RccId3_r0qFoupm2rxp8ajEpRNSln8BjC_Vxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1506207723</pqid></control><display><type>article</type><title>N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Weber, Michael, MD ; Bazzino, Oscar, MD ; Navarro Estrada, Jose L., MD ; Fuselli, Juan J., MD ; Botto, Fernando, MD ; Perez de Arenaza, Diego, MD ; Möllmann, Helge, MD ; Nef, Holger N., MD ; Elsässer, Albrecht, MD ; Hamm, Christian W., MD</creator><creatorcontrib>Weber, Michael, MD ; Bazzino, Oscar, MD ; Navarro Estrada, Jose L., MD ; Fuselli, Juan J., MD ; Botto, Fernando, MD ; Perez de Arenaza, Diego, MD ; Möllmann, Helge, MD ; Nef, Holger N., MD ; Elsässer, Albrecht, MD ; Hamm, Christian W., MD</creatorcontrib><description>N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission Michael Weber, Oscar Bazzino, Jose L. Navarro Estrada, Juan J. Fuselli, Fernando Botto, Diego Perez de Arenaza, Helge Möllmann, Holger N. Nef, Albrecht Elsässer, Christian W. Hamm We aimed to determine the prognostic value of N-terminal B-type natriuretic peptide (NT-proBNP) in 2,614 troponin negative (troponin T ≤0.01 ng/ml) patients from 2 different registries with evident or suspected acute coronary syndromes (ACS). In these two cohorts, receiver-operating characteristic curve analysis yielded an optimal cutoff value of 474 pg/ml for NT-proBNP that was able to discriminate patients at higher risk in the Bad Nauheim ACS and Prognosis in Acute Coronary Syndromes registries (mortality rate 12.3% vs. 1.3%, p &lt; 0.001 and 8.5% vs. 1.5%, p &lt; 0.001, respectively). Therefore, our study, in combination with previously published data, strongly suggests the implementation of NT-proBNP assessment for risk stratification of patients with chest pain or suspected non–ST-segment elevation ACS and negative troponin values.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2007.11.054</identifier><identifier>PMID: 18355657</identifier><identifier>CODEN: JACCDI</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acute Coronary Syndrome - blood ; Acute Coronary Syndrome - diagnosis ; Acute coronary syndromes ; Aged ; Angina pectoris ; Biological and medical sciences ; Biomarkers - blood ; Cardiology ; Cardiology. Vascular system ; Cardiovascular ; Cohort Studies ; Coronary heart disease ; Coronary vessels ; Electrocardiography ; Female ; Heart ; Heart attacks ; Humans ; Internal Medicine ; Male ; Medical sciences ; Middle Aged ; Myocarditis. Cardiomyopathies ; Natriuretic Peptide, Brain - blood ; Peptide Fragments - blood ; Predictive Value of Tests ; Prognosis ; Risk Assessment ; Sensitivity and Specificity ; Troponin T - blood</subject><ispartof>Journal of the American College of Cardiology, 2008-03, Vol.51 (12), p.1188-1195</ispartof><rights>American College of Cardiology Foundation</rights><rights>2008 American College of Cardiology Foundation</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Elsevier Limited Mar 25, 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-a65016244035941a8c5d79a4e0c4ab58132ce9d3e5ac9fb8781d6af3b7e2dab93</citedby><cites>FETCH-LOGICAL-c503t-a65016244035941a8c5d79a4e0c4ab58132ce9d3e5ac9fb8781d6af3b7e2dab93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2007.11.054$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20218305$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18355657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weber, Michael, MD</creatorcontrib><creatorcontrib>Bazzino, Oscar, MD</creatorcontrib><creatorcontrib>Navarro Estrada, Jose L., MD</creatorcontrib><creatorcontrib>Fuselli, Juan J., MD</creatorcontrib><creatorcontrib>Botto, Fernando, MD</creatorcontrib><creatorcontrib>Perez de Arenaza, Diego, MD</creatorcontrib><creatorcontrib>Möllmann, Helge, MD</creatorcontrib><creatorcontrib>Nef, Holger N., MD</creatorcontrib><creatorcontrib>Elsässer, Albrecht, MD</creatorcontrib><creatorcontrib>Hamm, Christian W., MD</creatorcontrib><title>N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission Michael Weber, Oscar Bazzino, Jose L. Navarro Estrada, Juan J. Fuselli, Fernando Botto, Diego Perez de Arenaza, Helge Möllmann, Holger N. Nef, Albrecht Elsässer, Christian W. Hamm We aimed to determine the prognostic value of N-terminal B-type natriuretic peptide (NT-proBNP) in 2,614 troponin negative (troponin T ≤0.01 ng/ml) patients from 2 different registries with evident or suspected acute coronary syndromes (ACS). In these two cohorts, receiver-operating characteristic curve analysis yielded an optimal cutoff value of 474 pg/ml for NT-proBNP that was able to discriminate patients at higher risk in the Bad Nauheim ACS and Prognosis in Acute Coronary Syndromes registries (mortality rate 12.3% vs. 1.3%, p &lt; 0.001 and 8.5% vs. 1.5%, p &lt; 0.001, respectively). Therefore, our study, in combination with previously published data, strongly suggests the implementation of NT-proBNP assessment for risk stratification of patients with chest pain or suspected non–ST-segment elevation ACS and negative troponin values.</description><subject>Acute Coronary Syndrome - blood</subject><subject>Acute Coronary Syndrome - diagnosis</subject><subject>Acute coronary syndromes</subject><subject>Aged</subject><subject>Angina pectoris</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Cohort Studies</subject><subject>Coronary heart disease</subject><subject>Coronary vessels</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Peptide Fragments - blood</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Risk Assessment</subject><subject>Sensitivity and Specificity</subject><subject>Troponin T - blood</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kt2O0zAQhSMEYsvCC3CBLCG4S7GTOHYktFKp-Km0KpW2C5eWa0_AJbGLnazU1-IJmagVK-0FV3HG35lMzpkse8nonFFWv9vP99qYeUGpmDM2p7x6lM0Y5zIveSMeZzMqSp4z2oiL7FlKe0ppLVnzNLtgsuS85mKW_VnnW4i987ojH_Lt8QBkrYfoxgiDM2QDh8FZIIuUIKUe_EA2MdxhKZGVNxGmEkqx-MOHNElWvg2x14MLnjhPNnhCJpHvbvhJFmYcgCxDDF7HI7k5ehtDj820t2Q96TqyjeEQPEq35JvuRry8xXeysL1LCbs-z560ukvw4vy8zG4_fdwuv-TXXz-vlovr3HBaDrmuOZpUVBVFNyqmpeFWNLoCaiq945KVhYHGlsC1adqdFJLZWrflTkBh9a4pL7O3p76HGH7jGIPCAQx0nfYQxqRqSRsumEDw9QNwH8aIjibFOK0LKkRRIlWcKBNDShFadYiuRxcUo2rKU-3VlKea8lSMKcwTRa_OrcddD_Zecg4QgTdnQCejuzZqb1z6xxW0QJRy5N6fOEDH7hxElQzmYsC6CGZQNrj_z3H1QG465x1-8RccId3_r0qFoupm2rxp8ajEpRNSln8BjC_Vxg</recordid><startdate>20080325</startdate><enddate>20080325</enddate><creator>Weber, Michael, MD</creator><creator>Bazzino, Oscar, MD</creator><creator>Navarro Estrada, Jose L., MD</creator><creator>Fuselli, Juan J., MD</creator><creator>Botto, Fernando, MD</creator><creator>Perez de Arenaza, Diego, MD</creator><creator>Möllmann, Helge, MD</creator><creator>Nef, Holger N., MD</creator><creator>Elsässer, Albrecht, MD</creator><creator>Hamm, Christian W., MD</creator><general>Elsevier Inc</general><general>Elsevier Science</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20080325</creationdate><title>N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission</title><author>Weber, Michael, MD ; Bazzino, Oscar, MD ; Navarro Estrada, Jose L., MD ; Fuselli, Juan J., MD ; Botto, Fernando, MD ; Perez de Arenaza, Diego, MD ; Möllmann, Helge, MD ; Nef, Holger N., MD ; Elsässer, Albrecht, MD ; Hamm, Christian W., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-a65016244035941a8c5d79a4e0c4ab58132ce9d3e5ac9fb8781d6af3b7e2dab93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acute Coronary Syndrome - blood</topic><topic>Acute Coronary Syndrome - diagnosis</topic><topic>Acute coronary syndromes</topic><topic>Aged</topic><topic>Angina pectoris</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Cohort Studies</topic><topic>Coronary heart disease</topic><topic>Coronary vessels</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Peptide Fragments - blood</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Risk Assessment</topic><topic>Sensitivity and Specificity</topic><topic>Troponin T - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weber, Michael, MD</creatorcontrib><creatorcontrib>Bazzino, Oscar, MD</creatorcontrib><creatorcontrib>Navarro Estrada, Jose L., MD</creatorcontrib><creatorcontrib>Fuselli, Juan J., MD</creatorcontrib><creatorcontrib>Botto, Fernando, MD</creatorcontrib><creatorcontrib>Perez de Arenaza, Diego, MD</creatorcontrib><creatorcontrib>Möllmann, Helge, MD</creatorcontrib><creatorcontrib>Nef, Holger N., MD</creatorcontrib><creatorcontrib>Elsässer, Albrecht, MD</creatorcontrib><creatorcontrib>Hamm, Christian W., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weber, Michael, MD</au><au>Bazzino, Oscar, MD</au><au>Navarro Estrada, Jose L., MD</au><au>Fuselli, Juan J., MD</au><au>Botto, Fernando, MD</au><au>Perez de Arenaza, Diego, MD</au><au>Möllmann, Helge, MD</au><au>Nef, Holger N., MD</au><au>Elsässer, Albrecht, MD</au><au>Hamm, Christian W., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2008-03-25</date><risdate>2008</risdate><volume>51</volume><issue>12</issue><spage>1188</spage><epage>1195</epage><pages>1188-1195</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><coden>JACCDI</coden><abstract>N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission Michael Weber, Oscar Bazzino, Jose L. Navarro Estrada, Juan J. Fuselli, Fernando Botto, Diego Perez de Arenaza, Helge Möllmann, Holger N. Nef, Albrecht Elsässer, Christian W. Hamm We aimed to determine the prognostic value of N-terminal B-type natriuretic peptide (NT-proBNP) in 2,614 troponin negative (troponin T ≤0.01 ng/ml) patients from 2 different registries with evident or suspected acute coronary syndromes (ACS). In these two cohorts, receiver-operating characteristic curve analysis yielded an optimal cutoff value of 474 pg/ml for NT-proBNP that was able to discriminate patients at higher risk in the Bad Nauheim ACS and Prognosis in Acute Coronary Syndromes registries (mortality rate 12.3% vs. 1.3%, p &lt; 0.001 and 8.5% vs. 1.5%, p &lt; 0.001, respectively). Therefore, our study, in combination with previously published data, strongly suggests the implementation of NT-proBNP assessment for risk stratification of patients with chest pain or suspected non–ST-segment elevation ACS and negative troponin values.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>18355657</pmid><doi>10.1016/j.jacc.2007.11.054</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2008-03, Vol.51 (12), p.1188-1195
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_68095717
source MEDLINE; Elsevier ScienceDirect Journals Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Acute Coronary Syndrome - blood
Acute Coronary Syndrome - diagnosis
Acute coronary syndromes
Aged
Angina pectoris
Biological and medical sciences
Biomarkers - blood
Cardiology
Cardiology. Vascular system
Cardiovascular
Cohort Studies
Coronary heart disease
Coronary vessels
Electrocardiography
Female
Heart
Heart attacks
Humans
Internal Medicine
Male
Medical sciences
Middle Aged
Myocarditis. Cardiomyopathies
Natriuretic Peptide, Brain - blood
Peptide Fragments - blood
Predictive Value of Tests
Prognosis
Risk Assessment
Sensitivity and Specificity
Troponin T - blood
title N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T08%3A28%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-Terminal%20B-Type%20Natriuretic%20Peptide%20Assessment%20Provides%20Incremental%20Prognostic%20Information%20in%20Patients%20With%20Acute%20Coronary%20Syndromes%20and%20Normal%20Troponin%20T%20Values%20Upon%20Admission&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Weber,%20Michael,%20MD&rft.date=2008-03-25&rft.volume=51&rft.issue=12&rft.spage=1188&rft.epage=1195&rft.pages=1188-1195&rft.issn=0735-1097&rft.eissn=1558-3597&rft.coden=JACCDI&rft_id=info:doi/10.1016/j.jacc.2007.11.054&rft_dat=%3Cproquest_cross%3E68095717%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1506207723&rft_id=info:pmid/18355657&rft_els_id=1_s2_0_S0735109708000788&rfr_iscdi=true